Seres Therapeutics, Inc. (MCRB): Cash & Equivalents
$45.77M
As of 2025-12-31
$15.59M
As of 2026-06-30
-34.5%
3-year compound annual growth
-17.0%
5-year compound annual growth
-4.7%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $45.77M | +48.6% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $30.79M | -75.9% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $127.97M | -21.5% | 2025-03-13, Balance as of period end |
| 2022-12-31 | $163.03M | -9.4% | 2024-03-05, Balance as of period end |
| 2021-12-31 | $180.00M | +55.1% | 2023-03-07, Balance as of period end |
| 2020-12-31 | $116.05M | +78.2% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $65.13M | -24.1% | 2021-03-02, Balance as of period end |
| 2018-12-31 | $85.82M | +137.8% | 2020-03-02, Balance as of period end |
| 2017-12-31 | $36.09M | -33.8% | 2019-03-06, Balance as of period end |
| 2016-12-31 | $54.54M | -26.2% | 2019-03-06, Balance as of period end |
| 2015-12-31 | $73.93M | -35.3% | 2018-03-08, Balance as of period end |
| 2014-12-31 | $114.19M | n/m | 2017-03-16, Balance as of period end |
| 2013-12-31 | $1.65M | n/a | 2016-03-14, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | 2025-12-31 | $45.77M | +48.6% |
| Monopar Therapeutics (MNPR) | 2025-12-31 | $61.83M | +35.0% |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | $35.26M | +182.6% |
| Silence Therapeutics plc (SLN) | 2025-12-31 | $11.28M | -90.7% |
| Larimar Therapeutics, Inc. (LRMR) | 2025-12-31 | $85.41M | +157.1% |
| Citius Pharmaceuticals, Inc. (CTXR) | 2025-09-30 | $4.25M | +30.8% |
| Acrivon Therapeutics, Inc. (ACRV) | 2025-12-31 | $41.50M | +4.2% |
| XBiotech Inc. (XBIT) | 2025-12-31 | $125.55M | -27.3% |
| Zomedica Corp. (ZOMDF) | 2025-12-31 | $9.02M | +28.4% |
Compare MCRB, MNPR, PRLD, SLN side by side · Screen every company in Pharmaceutical Preparations ↗